pulmonary hypertension and pregnancy

Pulmonary arterial hypertension (PAH) and pregnancy are interrelated physiological conditions that can significantly impact each other. Typically, women with PAH may encounter heightened health risks during gestation.

PAH is a cardiovascular disorder characterized by elevated blood pressure in the pulmonary arteries, which in turn increases the heart's workload. Throughout pregnancy, a woman's body undergoes numerous changes, such as an increase in blood volume and cardiac output, which can further strain the heart in women with PAH. While mild PAH may not significantly affect pregnancy, more severe cases can lead to symptoms like shortness of breath, fatigue, and fainting in pregnant women, and in extreme cases, may result in heart failure, restricted fetal growth, or preterm birth. Thus, it is crucial for pregnant women with PAH to have regular monitoring of their condition and to adhere to the guidance and recommendations provided by their healthcare providers.

For individuals with PAH contemplating pregnancy, it is advised to consult a physician prior to conception to evaluate personal health status and potential risks, and to manage pregnancy under medical supervision. Pregnant women should also engage in regular prenatal care and closely monitor their own health as well as that of their fetus. Should any symptoms of discomfort arise, they should seek immediate medical attention and disclose their medical history and current treatment regimen to their healthcare provider. During treatment, pregnant women must strictly follow prescribed medication instructions and avoid altering dosages or discontinuing medication without professional guidance.